Sun Pharmaceutical Industries Ltd. v. Pr.CIT
162 ITD 484Income Tax Appellate Tribunal2017#2441 most cited
What is Sun Pharmaceutical Industries Ltd. v. Pr.CIT authority for?
The approval of an in-house R&D centre through Form 3CM is the primary document for claiming weighted deduction under Section 35(2AB) for scientific research expenditure. The case clarifies the significance of this form and the role of the prescribed authority (DSIR) in the approval process.
47
judgments rely on this decision, according to BharatTax’s citation analysis of 292,668 Indian tax judgments — from 2018 to 2025.
Also referred to as
Sun Pharmaceutical Industries Ltd. v. Pr.CIT · 162 ITD 484 · Section 35(2AB) · weighted deduction · scientific research expenditure · in-house R&D centre approval · Form 3CM · DSIR · Section 35(1)(i)
Sections most often in play
Issues it is cited on
Judgments citing Sun Pharmaceutical Industries Ltd. v. Pr.CIT
Showing 1–20 of 47 · Page 1 of 3